Methysergide (Sansert) Treatment in Acute Stroke Community Pilot Study

Weintraub, Michael I.
March 1985
Angiology;Mar1985, Vol. 36 Issue 3, p137
Academic Journal
Since its first discovery in 1948,' serotonin (5-HT) has been the subject of considerable interest. Its potent vasoactivity led to the hypothesis that altered serotonin metabolism was responsible for the pathophysiology of cerebrovascular disease (infarction & hemorrhage) with documentation of elevated levels of serotonin in CSF. If (5-HT) serotonin-mediated release is ultimately responsible for cerebral edema, vasospasm and infarction in experimental and human stroke, then an opportunity exists to pharmacologically block these effects with serotonin-antagonizing agents. This hypothesis has been tested in the laboratory with several agents that inhibit biogenic amines resulting in promising data suggesting a reduction in damage and disability. Since the "natural history of human stroke" results in a 30-40% mortality within the first three weeks, an aggresive new attempt should be directed to increasing the number of survivors in this initial period of high risk. In this regard Sansert (methysergide) was considered worthy of clinical trials.


Related Articles

  • Vasospasm: The enigma of subarachnoid hemorrhage. Sharma, Bhawani Shanker; Sawarkar, Dattaraj Paramanand // Neurology India;Jul/Aug2015, Vol. 63 Issue 4, p483 

    The article discusses aspects of cerebral vasospasm. Topics include the risk factors of vasospasm, the occurrence of cerebrovascular vasospasm following subarachnoid hemorrhage, and the pathophysiology of vasospasm. Also included is the study conducted by H. Yoneda and colleagues which...

  • Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm. Armstead, W. M. // Current Pharmaceutical Design;Jul2004, Vol. 10 Issue 18, p2185 

    Increasing evidence implicates endothelin in the pathophysiological development of cerebral vasospasm. This review summarizes background topics such as the structures and biosynthesis of endothelins, the types of endothelin and their receptors, as well as their biological effects. Basic science...

  • Ginsenoside RB1 Reduces Neurologic Damage, is Anti-Apoptotic, and Down-Regulates p53 and BAX in Subarachnoid Hemorrhage. Yingbo Li; Jiping Tang; Khatibi, Nikan H.; Mei Zhu; Di Chen; Weiping Zheng; Shali Wang // Current Neurovascular Research;May2010, Vol. 7 Issue 2, p85 

    Stroke is the second leading cause of death worldwide and the number one cause of adult disability in the United States and Europe. A subtype of stroke, subarachnoid hemorrhage (SAH), accounts for 7% of all strokes each year and claims one of the highest mortalities and morbidities. Many...

  • Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. Pyne-Geithman, Gail J.; Morgan, Chad J.; Wagner, Kenneth; Dulaney, Elizabeth M.; Carrozzella, Janice; Kanter, Daniel S.; Zuccarello, Mario; Clark, Joseph F. // Journal of Cerebral Blood Flow & Metabolism;Aug2005, Vol. 25 Issue 8, p1070 

    Delayed cerebral vasospasm after subarachnoid hemorrhage (SAH) remains a significant cause of mortality and morbidity; however, the etiology is, as yet, unknown, despite intensive research efforts. Research in this laboratory indicates that bilirubin and oxidative stress may be responsible by...

  • SIGNS OF A STROKE. Donaldson, Doug // Better Homes & Gardens;Apr2006, Vol. 84 Issue 4, p274 

    The article provides information about stroke and gives tips on how to identify its symptoms. There exists two kinds of stroke, one is caused by clots in the proper blood flow while the other is caused by broken blood vessels in the brain. Symptoms include the inability of a person to raise both...

  • Importance of anthropometric indices in subarachnoid hemorrhage. Srivastava, Amit; Kumar, Pallav; Mehta, Veer Singh // Neurology India;Jul/Aug2015, Vol. 63 Issue 4, p486 

    The article discusses the study conducted by Dhandapani and colleagues whic emphasizes the importance of anthropometric indices in subarachnoid hemorrhage (SAH). The study found a decrease in the median mid upper arm circumference despite having achieved the target of total nutritional...

  • Reversal of Radiographically Impending Stroke with Multiple Intraarterial Papaverine Infusions in Severe Diffuse Cerebral Vasospasm Induced by Subarachnoid Hemorrhage. Liu, J. K.; Tenner, M. S.; Oestreich, H. M.; Couldwell, W. T. // Acta Neurochirurgica;Dec2001, Vol. 143 Issue 12, p1249 

    Summary.Background: Selective intraarterial infusion of papaverine is used in the treatment of symptomatic cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage (SAH). Delays in instituting therapy for vasospasm can lead to irreversible cerebral infarction and a devastating outcome....

  • Endothelin and Subarachnoid Hemorrhage-Induced Cerebral Vasospasm: Pathogenesis and Treatment. Chih-Lung Lin; Jeng, Arco Y.; Shen-Long Howng; Aij-Lie Kwan // Current Medicinal Chemistry;Jul2004, Vol. 11 Issue 13, p1779 

    Endothelin (ET)-mediated vasoconstriction has been implicated in the pathophysiology of various disorders, e.g. hypertension, chronic heart failure, acute renal failure, pulmonary hypertension, and subarachnoid hemorrhage (SAH)-induced cerebral vasospasm. The potential involvement of ETs in...

  • Topical Application of Dexamethasone to Prevent Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage: A Pilot Study. Luo Fei; Golwa, Filimon // Clinical Drug Investigation;2007, Vol. 27 Issue 12, p827 

    BACKGROUND: and objective: Cerebral vasospasm is a common and serious complication of aneurysmal subarachnoid haemorrhage (SAH). Many studies have revealed a role of inflammation in the development of cerebral vasospasm. This study aimed to investigate whether topically administered...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics